A detailed history of N Verses Capital, LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 300 shares of STTK stock, worth $330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 3,300 90.91%
Holding current value
$330
Previous $12.7 Million 91.78%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$3.0 - $4.85 $9,000 - $14,549
-3,000 Reduced 90.91%
300 $1.05 Million
Q2 2024

Jul 31, 2024

BUY
$3.56 - $11.18 $11,748 - $36,894
3,300 New
3,300 $12.7 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.